Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy
LR Zacharski - Cancer letters, 2002 - Elsevier
The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …
Treatment of malignancy by activation of the plasminogen system
LR Zacharski, DL Ornstein, EC Gabazza… - … in thrombosis and …, 2002 - thieme-connect.com
The blood coagulation mechanism in general and the plasminogen system in particular
contribute to malignant growth and dissemination in complex ways. This article reviews the …
contribute to malignant growth and dissemination in complex ways. This article reviews the …
A rebuttal: vitamin K antagonists and cancer survival
LR Zacharski, WG Henderson - Thrombosis and haemostasis, 2002 - thieme-connect.com
1TQ ietters to the Editor because it is used commonly in patients with malignancy
complicated by deep vein thrombosis and can be given chronically on an outpatient basis …
complicated by deep vein thrombosis and can be given chronically on an outpatient basis …